Results for tag: "Shigella Molecular Diagnostics"

The Shigella Molecular Diagnostics market is a segment of the Infectious Disease Testing market. It is focused on the detection and identification of Shigella bacteria, which are responsible for causing shigellosis, a type of gastroenteritis. Molecular diagnostics are used to detect the presence of Shigella bacteria in clinical samples, such as stool, and to identify the species and serotype of the bacteria. Molecular diagnostics are more sensitive and specific than traditional culture-based methods, and can provide results in a shorter time frame. The Shigella Molecular Diagnostics market is driven by the increasing prevalence of shigellosis, the growing demand for rapid and accurate diagnosis, and the increasing adoption of molecular diagnostics. The market is further supported by the availability of advanced technologies, such as real-time PCR and next-generation sequencing. Some companies in the Shigella Molecular Diagnostics market include Bio-Rad Laboratories, Cepheid, Hologic, Qiagen, Roche Diagnostics, and Thermo Fisher Scientific. Show Less Read more